![Samir Gharib](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samir Gharib
Directeur Financier/CFO chez
SPRUCE BIOSCIENCES, INC.
Fortune : 423 644 $ au 31/05/2026
Profil
Samir M.
Gharib is currently the Director at Cancer CAREpoint since 2017.
Mr. Gharib is also the President & Chief Financial Officer at Spruce Biosciences, Inc. since 2022.
Formerly, Mr. Gharib was Finance Director & Controller at Talon Therapeutics, Inc. from 2012 to 2013.
Mr. Gharib was Managing Director at Benchmark Financial Partners LLC from 2017 to 2018.
Mr. Gharib was Vice President-Finance & Administration at Revance Therapeutics, Inc. from 2013 to 2017.
Mr. Gharib was Chief Financial Officer at Stemedica Cell Technologies, Inc. from 2018 to 2019.
Education includes an undergraduate degree conferred in 2005 and an MBA from Haas School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SPRUCE BIOSCIENCES, INC. 0,77 % | 24/03/2026 | 8 263 ( 0,77 % ) | 423 644 $ | 31/05/2026 |
Postes actifs de Samir Gharib
| Sociétés | Poste | Début |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Directeur Financier/CFO | 01/05/2020 |
Cancer CAREpoint
 Cancer CAREpoint Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for treatment of cancer | Directeur/Membre du Conseil | 01/11/2017 |
Anciens postes connus de Samir Gharib
| Sociétés | Poste | Fin |
|---|---|---|
Stemedica Cell Technologies, Inc.
 Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures adult stem cells | Directeur Financier/CFO | 01/09/2019 |
Benchmark Financial Partners LLC | Corporate Officer/Principal | 01/10/2018 |
| REVANCE THERAPEUTICS, INC. | Directeur Financier/CFO | 01/09/2017 |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Directeur Financier/CFO | 01/09/2013 |
Formation de Samir Gharib
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Revance Therapeutics, Inc.
 Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures adult stem cells | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spruce Biosciences, Inc.
 Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company which develops novel therapies for endocrine diseases | Health Technology |
Cancer CAREpoint
Cancer CAREpoint Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for treatment of cancer | Commercial Services |
Benchmark Financial Partners LLC |
